跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BYLVAY 400 MICROGRAMOS CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BYLVAY 400 MICROGRAMOS CAPSULAS DURAS
Approved
STANDARD
BYLVAY 400 MICROGRAMOS CAPSULAS DURAS
Ipsen Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 21, 2021
Approval ID
f04d6ed0086ff879
Company
Ipsen Pharma
Type
Standard
Approval Details
Approval Id
f04d6ed0086ff879
Drug Cima Aemps Name
BYLVAY 400 MICROGRAMOS CAPSULAS DURAS
Register Number
1211566002
Holder Company Name
Ipsen Pharma
Marketing Company Name
Ipsen Pharma S.A.
Holder Company Detail Path
/organization/ipsen-pharma
Authorization Date
2021-12-21
Dosage Form
CÁPSULA DURA
Dose
200 - REVISAR µg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Ipsen Pharma
Company Detail Path
/organization/ipsen-pharma
Company Information
Pharmaceutical Company Name
IPSEN PHARMA
Country Name
France
City Name
boulogne-billancourt,ile de france,country_fr
Address
65 QUAI GEORGES GORSE
Active Ingredients
ODEVIXIBAT SESQUIHIDRATO
0,414 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 21, 2021
Approval ID
f04d6ed0086ff879
Type
Standard
Back to CIMA-AEMPS Approvals